| Chen, HuiSheng |
ERSAF, NCT03749057: Early Rivaroxaban for Acute Ischemic Stroke or TIA Patients With Atrial Fibrillation |
|
|
| Recruiting | 4 | 400 | RoW | Rivaroxaban | General Hospital of Shenyang Military Region | Cerebral Infarction, TIA | 11/24 | 11/24 | | |
| Recruiting | 4 | 40 | RoW | Fingolimod, guideline-based treatment for DM | General Hospital of Shenyang Military Region | Diabetes Mellitus, Type 2 | 03/25 | 03/25 | | |
| Recruiting | 4 | 100 | RoW | Atorvastatin Calcium, Probucol, PCSK9 inhibitor | General Hospital of Shenyang Military Region | Stroke, Ischemic, Atherosclerosis, Cerebral | 11/24 | 11/24 | | |
| Completed | 3 | 1412 | RoW | Injection of recombinant human tissue plasminogen kinase derivatives, Reteplase, brand name: Ruitongli, r-PA, Recombinant human tissue plasminogen activator, Alteplase, brand name: Actilyse, rt-PA | Angde Biotech Pharmaceutical Co., Ltd., Beijing Tiantan Hospital | Acute Ischemic Stroke | 06/23 | 06/23 | | |
NCT05745259: Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-Ⅲ） |
|
|
| Recruiting | 3 | 1630 | RoW | Alteplase, rt-PA, Tenecteplase, TNK-tPA | Beijing Tiantan Hospital, Jiangsu FENG HUA Biotech Pharmaceutical Co., Ltd, The Place Pharmaceutical(Jiangsu) Co., Ltd | Acute Ischemic Stroke | 11/23 | 03/24 | | |
BHV3000-318, NCT05371652: A Study to Learn About the Long-term Safety of Rimegepant for the Acute Treatment of Migraine in Chinese Participants |
|
|
| Completed | 3 | 241 | RoW | Rimegepant 75mg Orally Disintegrating Tablets (ODT) | Pfizer, Bioshin (Shanghai) Consulting Services Co., Ltd | Acute Migraine | 02/24 | 02/24 | | |
NCT05897645: High-resolution Magnetic Resonance Imaging of Intracranial Atherosclerotic Plaques in Ischemic Stroke |
|
|
| Recruiting | N/A | 2110 | RoW | Registration | General Hospital of Shenyang Military Region | Stroke, Intracranial Atherosclerosis, High Resolution Magnetic Resonance Imaging | 01/26 | 01/26 | | |
| Tao, Lin |
| No trials found |
